+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A randomized comparison of one single dose of vaginal 50 microg misoprostol with 3 mg dinoprostone in pre-induction cervical ripening



A randomized comparison of one single dose of vaginal 50 microg misoprostol with 3 mg dinoprostone in pre-induction cervical ripening



Journal of the Medical Association of Thailand 83(9): 1026-1034



To compare the efficacy and safety of one single dose of 50 pg misoprostol to one single dose of 3 mg dinoprostone administered vaginally for pre-induction cervical ripening in term-pregnant women, who had indications for induction of labor with unripe cervices. A randomized double-blind controlled trial. Bangkok Metropolitan Administration Medical College and Vajira Hospital, Bangkok, Thailand. One hundred and forty-three singleton pregnant women of > or = 37 weeks of gestation, who had indications for termination of pregnancy. All patients had a Bishop score of 0-6, without contraindications for labor induction. The subjects were stratified by parity to nullipara and multipara group. The subjects in each stratum were allocated by randomization to receive a single dose of 50 microg misoprostol or 3 mg dinoprostone, administered vaginally. Twenty-four hours after medication, oxytocin augmentation was given to both groups. The Bishop score of cervix at 24 hours after insertion of the studied drugs, the occurrence of abnormal uterine contraction, and the number of vaginal deliveries within 24, 48 hours. The demographic data and the initial Bishop score (median score 3.5 versus 4.0) were comparable in both groups. The change of score at 24 hours was one unit higher in misoprostol-treated patients compared with dinoprostone-treated patients (mean change score 6.5 versus 5.5, with 95 per cent CI 0.04 to 2.1, p=0.042) but was not of clinical importance. There was a higher frequency of hyperstimulation syndrome in the misoprostol group (6.9% vs 0%) during 8 hours of cervical ripening. Although the difference was not statistically significant (p=0.058), it was clinically important. Comparing vaginal deliveries between the misoprostol and dinoprostone groups, the frequencies of delivery within 24 hours were 46.3 per cent versus 35.7 per cent (p=0.350), and within 48 hours were 88.9 per cent versus 89.3 per cent (p>0.05), non-significantly different. No significant differences were noted between misoprostol and dinoprostone in terms of interval from start of medication to vaginal delivery and neonatal outcomes. The efficacy of a single 50 microg dose of vaginally administered misoprostol, is not clinically different to 3 mg dinoprostone in cervical ripening. Although the study was not sufficiently large to detect the differences in abnormal uterine contractions between the two groups, there was a higher frequency of hyperstimulation syndrome in the misoprostol group compared to the dinoprostone group. Close utero-fetal monitoring in misoprostol-treated patients is needed.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045101770

Download citation: RISBibTeXText

PMID: 11075969


Related references

Comparison between vaginal misoprostol and cervical dinoprostone for cervical ripening and labor induction; a randomized study. American Journal of Obstetrics & Gynecology 178(1 Part 2): S94, 1998

A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction. Journal of the Medical Association of Thailand 88(Suppl. 2): S56-S62, 2005

Comparison between vaginal misoprostol and cervical dinoprostone for cervical ripening and labor induction. Tennessee Medicine 94(1): 25-27, 2001

Pre-induction cervical ripening with 25 microg and 50 microg vaginal misoprostol in 181 nulliparous parturients. Journal of Maternal-Fetal and Neonatal Medicine 22(3): 265-268, 2009

Randomized comparison of misoprostol vs dinoprostone for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 176(1 Part 2): S141, 1997

A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. American Journal Of Obstetrics & Gynecology. 177(3): 612-618, 1997

Randomized comparison of misoprostol and dinoprostone for preinduction cervical ripening and labor induction. Journal of the Formosan Medical Association 96(5): 366-369, 1997

Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor. American Journal of Obstetrics & Gynecology 181(3): 626-629, 1999

Oral misoprostol (100 microg) versus vaginal misoprostol (25 microg) in term labor induction: a randomized comparison. Acta Obstetricia et Gynecologica Scandinavica 82(12): 1103-1106, 2003

Oral Misoprostol and Intracervical Dinoprostone for Cervical Ripening and Labor Induction: A Randomized Comparison. Journal of Midwifery & Women's Health 46(3): 203-204, 2001

Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: A randomized comparison. Obstetrics & Gynecology 96(3): 465-469, 2000

A comparison of intermittent vaginal administration of two different doses of misoprostol suppositories with continuous dinoprostone for cervical ripening and labor induction. Journal of Maternal-Fetal Medicine 10(3): 186-192, 2001

A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices. Obstetrics and Gynecology 89(4): 581-585, 1997

Efficacy and safety of administering oral misoprostol by titration compared to vaginal misoprostol and dinoprostone for cervical ripening and induction of labour: study protocol for a randomised clinical trial. Bmc Pregnancy and Childbirth 19(1): 14, 2019

Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction. Journal of Obstetrics and Gynaecology Research 29(3): 147-151, 2003